Claims
- 1. A solid, rapidly absorbable composition by weight consisting of 1 part by weight of nimodipine, 0.01 to 1.5 parts of polyvinylpyrrolidone with an average molecular weight of 15,000 to 50,000 and 1 to 12 parts by weight of crosslinked insoluble polyvinylpyrrolidone.
- 2. A solid, rapidly absorbable composition by weight consisting of 1 part of a dihydropyridine, 0.01 to 1.5 parts polyvinylpyrrolidone with an average molecular weight of 15,000 to 50,000, 1 to 12 parts by weight of crosslinked insoluble polyvinylpyrrolidone, the dihydropyridine being selected from the group consisting of nifedipine, nimodipine, nitrendipine, nisoldipine and felodipine optionally sodium lauryl sulfate and optionally magnesium stearate.
- 3. A composition according to claim 2, containing 0.05 to 1.5 parts by weight of polyvinylpyrrolidone and 2 to 8 parts by weight of crosslinked insoluble polyvinylpyrrolidone.
- 4. A composition according to claim 2, containing 0.1 to 1 part by weight of polyvinylpyrrolidone and 2 to 6 parts by weight of crosslinked insoluble polyvinylpyrrolidone.
- 5. A composition according to claim 2, free of solvent.
- 6. A unit dose of a composition according to claim 2, in the form of granules, powders, a tablet or dragee.
Priority Claims (1)
Number |
Date |
Country |
Kind |
3424553 |
Jul 1984 |
DEX |
|
Parent Case Info
This application is a continuation-in-part of application Ser. No. 467,316, filed Jan. 18, 1990, now abandoned, which is a continuation of application Ser. No. 750,560, filed Jun. 27, 1985, now abandoned.
US Referenced Citations (6)
Foreign Referenced Citations (2)
Number |
Date |
Country |
0001247 |
Apr 1979 |
EPX |
1173862 |
Dec 1969 |
GBX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
750566 |
Jun 1985 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
467316 |
Jan 1990 |
|